In a study with mice, researchers at Johns Hopkins Bloomberg School of Public Health have found that e-cigarettes compromise the immune system in the lungs and generate some of the same potentially dangerous chemicals found in traditional nicotine cigarettes.
E-cigarettes are an emerging public health health concern, as they gain popularity among current and former smokers as well as those who have never smoked, including teenagers. The perception that e-cigarettes pose little health risk is so entrenched that some smokers, including those with chronic obstructive pulmonary disease ( COPD ), are switching from cigarettes to e-cigarettes.
Both cigarettes and e-cigarettes are sources of Nicotine. E-cigarettes contain less Nicotine than cigarettes, but actual Nicotine intake by e-cigarette users can approximate that of cigarette smokers.
The findings, published in the journal PLOS ONE, suggest that e-cigarettes are not neutral in terms of the effects on the lungs. They increase the susceptibility to respiratory infections in the mouse models.
This warrants further study in susceptible individuals, such as COPD patients who have switched from cigarettes to e-cigarettes or to new users of e-cigarettes who may have never used cigarettes.
For their study, researchers divided the mice into two groups: one was exposed to e-cigarette vapor in an inhalation chamber in amounts that approximated actual human e-cigarette inhalation for two weeks, while the other group was just exposed to air.
The researchers then divided each group into three subgroups. One received nasal drops containing Streptococcus pneumoniae, a bacteria responsible for pneumonia and sinusitis, among other illnesses, in humans. A second received nasal drops of the virus Influenza A, and the third subgroup did not receive either virus or bacteria.
The mice exposed to e-cigarette vapor were significantly more likely to develop compromised immune responses to both the virus and the bacteria, which in some cases killed the mice, the researchers found.
E-cigarette vapor alone produced mild effects on the lungs, including inflammation and protein damage. However, when this exposure was followed by a bacterial or viral infection, the harmful effects of e-cigarette exposure became even more pronounced.
The e-cigarette exposure inhibited the ability of mice to clear the bacteria from their lungs, and the viral infection led to increased weight loss and death indicative of an impaired immune response.
Since their introduction to the U.S. market in 2007, e-cigarettes have prompted debate as to their risk in general and relative to cigarettes. E-cigarettes, which at their simplest consist of a battery, an atomizer and a cartridge, produce a vapor that is inhaled and then exhaled by the user. Previous analyses of e-cigarette vapor have identified chemicals that could be toxic or carcinogenic, including particulates, formaldehyde and volatile organic compounds, but at lower levels than cigarette smoke. Another thing working in the favor of e-cigarettes in the risk continuum is that they don't combust the way cigarettes do, limiting some of the chemicals released in cigarette smoke.
As part of their study, the researchers also determined that e-cigarette vapor contains free radicals, known toxins found in cigarette smoke and air pollution. Free radicals are highly reactive agents that can damage DNA or other molecules within cells, resulting in cell death.
Cigarette smoke contains 1014 free radicals per puff. Though e-cigarette vapor contains far fewer free radicals than cigarette smoke ( one percent as much ) their presence in e-cigarettes still suggests potential health risks that merit further study. ( Xagena )
Source: Johns Hopkins Bloomberg School of Public Health, 2015